| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.07 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.054 | 0.07 |